INmune Bio and QCi Combine Quantum Computing and AI to Study Drug Applications

<p>BOCA RATON, Fla. and HOBOKEN, N.J., Oct. 14, 2026 &#8212; INmune Bio Inc. and Quantum Computing Inc. (QCi) today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio&#8217;s investigational treatment for Alzheimer&#8217;s disease and other disease conditions. The collaboration brings together [&#8230;]</p> <p>The post <a href="https://www.hpcwire.com/off-the-wire/inmune-bio-and-qci-combine-quantum-computing-and-ai-to-study-drug-applications/">INmune Bio and QCi Combine Quantum Computing and AI to Study Drug Applications</a> appeared first on <a href="https://www.hpcwire.com">HPCwire</a>.</p>